Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity

被引：58

|

作者：

Pippa, R. ^{[1
]}

Dominguez, A. ^{[1
]}

Christensen, D. J. ^{[2
]}

Moreno-Miralles, I. ^{[1
]}

Blanco-Prieto, M. J. ^{[3
]}

Vitek, M. P. ^{[2
]}

Odero, M. D. ^{[1
,4
]}

机构：

[1] Univ Navarra, Ctr Appl Med Res CIMA, Hematol Oncol Program, Navarra, Spain

[2] Oncotide Pharmaceut, Res Triangle Pk, NC USA

[3] Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, Navarra, Spain

[4] Univ Navarra, Dept Biochem & Genet, Navarra, Spain

来源：

LEUKEMIA | 2014年 / 28卷 / 09期

关键词：

PROTEIN PHOSPHATASE 2A; INHIBITION; I-2(PP2A)/SET; ACTIVATION; EFFICACY; THERAPY; EVENT;

D O I：

10.1038/leu.2014.141

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1915 / 1918

页数：4

相关论文

共 23 条

[21] PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
I Cristóbal
L Garcia-Orti
C Cirauqui
M M Alonso
M J Calasanz
M D Odero
Leukemia, 2011, 25 : 606 - 614
[22] PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
Cristobal, I.
Garcia-Orti, L.
Cirauqui, C.
Alonso, M. M.
Calasanz, M. J.
Odero, M. D.
LEUKEMIA, 2011, 25 (04) : 606 - 614
[23] Potential Targeting Ph+ Acute Lymphoblastic Leukemia Stem and Progenitor Cells By Modulating the CIP2A-SET-SETBP1-Mediated Suppression of PP2A Activity
Yu, Justine
Silvestri, Giovannino
Stramucci, Lorenzo
Sanada, Masashi
Yamaguchi, Tomoyuki
Du, Yang
Westermarck, Jukka
Caligiuri, Michael A.
Garzon, Ramiro
Milojkovic, Dragana
Apperley, Jane F.
Roy, Denis-Claude
Marcucci, Guido
Calabretta, Bruno
Baer, Maria R.
Trotta, Rossana
Perrotti, Danilo
BLOOD, 2016, 128 (22)